共 129 条
[1]
Alexopoulos D(2014)Effects of P2Y12 receptor inhibition in patients with ST-segment elevation myocardial infarction Am J Cardiol 113 2064-2069
[2]
Xanthopoulou I(2012)ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2569-2619
[3]
Goudevenos J(2013)ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 e78-e140
[4]
Steg PG(2008)Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction Thromb Res 122 776-781
[5]
James SK(2012)FABOLUS PRO Investigators. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial J Am Coll Cardiol Interv 5 268-277
[6]
Atar D(2012)Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST elevation myocardial infarction Circ Cardiovasc Interv 5 797-804
[7]
Badano LP(2013)Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI study J Am Coll Cardiol 61 1601-1606
[8]
Blömstrom-Lundqvist C(2013)Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI J Am Coll Cardiol 62 940-941
[9]
O’Gara PT(2014)Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study Am Heart J 167 909-914
[10]
Kushner FG(2014)Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study Circ Cardiovasc Interv 7 233-239